Gastroenterology and Hepatology - Issue 1/2019
Editorial
5
News in 2019
Lukáš M.
IDB: Original Article
25
Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
Kolar M., Ďuricová D., Bortlík M., Pudilova K., Hrubá V., Machková N., Mitrová K., Malickova K., Lukas M. jr., Vasatko M., Vanickova R., Lukas M.
32
Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel disease
Pudilova K., Kolar M., Ďuricová D., Malickova K., Hrubá V., Machková N., Vanickova R., Mitrová K., Lukas M., Vasatko M., Bortlík M.
IBD: Review Article
37
Inflammatory bowel disease and medical assessment service
Matějková P., Vítková Z.
IBD: Case Report
43
Treatment of a pregnant Crohn’s disease patient with ustekinumab: a case report
Lukešová L., Nedbalová L., Šerclová Z.
46
Ileocaecal Crohn’s disease and familial adenomatous polyposis in one patient – a case report
Can V., Marek F., Kala Z., Poredská K., Kroupa R., Tvrdikova E., Andrasina T., Prochazka V., Kunovsky L.
Clinical and Experimental Gastroenterology: Case Report
52
Surprising etiology of terminal common bile duct stricture
Vašíček J., Horný I.
Clinical and Experimental Gastroenterology: Original Article
56
Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux
L. Nosáková, Ďuriček M., P. Bánovčin Jr., Gburová D., Lipták P., Hyrdel R.
Digestive Endoscopy: Original Article
62
Does abdominal compression improve the success rate of and tolerance to colonoscopy?
Kojecký V., Havlíčková Z., Gabrielová M., Haasová J., Machalová M., Kopečná H., Štekovičová B.
Chapters from internal medicine: Review Article
66
Toxic and drug damage of the liver and kidneys
Teplan V., Ševela K.
82
Gastroenterology and Hepatology
2019 Číslo 1
Najčítanejšie v tomto čísle
- Clensia® – the first combined cleansing agent with simeticone
- Toxic and drug damage of the liver and kidneys
- Surprising etiology of terminal common bile duct stricture
- Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux